Navigation Links
Asoyia Secures Venture Capital Funding

Soybean seed and oil company will focus on new business development of its

ULTRA low linolenic, trans fat-free products.

IOWA CITY, Iowa, May 1 /PRNewswire/ -- Asoyia has finalized an agreement with two key venture capital firms, securing $4 million to expand marketing, research and development of its ULTRA low linolenic soybean products. Asoyia is the innovator and leader in developing and providing the first and only commercially available soybean oils with the highest level of stability and zero trans fats per serving for the food industry. St. Louis-based Prolog Ventures led the round and was joined by LSP (Life Science Partners) of Boston.

Iowa-based Asoyia produces ULTRA Low Linolenic Soybean Oils (Asoyia-ULL) from the company's 1% ULTRA low linolenic soybeans. The innovative specialty soybeans keep the oil fresh and shelf-stable for two to three times longer than conventional oils thus eliminating the need for hydrogenation which creates trans fat. The FDA began requiring trans fat labeling on all packaged foods in 2006, fueling the food industry's demand for a viable non-hydrogenated oil alternative.

"The new partnership between Asoyia, Prolog and LSP is going to propel us from an established and growing entrepreneurial business into a major marketer of ULTRA low lin oil," said Greg Keeley, Asoyia CEO. "We have an incredibly good product and a demand that's been extremely strong due to the emphasis on health and wellness, the FDA's new labeling legislation, and the banning of trans fat containing oils in some communities like New York City. This will fund our passion for providing a viable, healthy alternative by giving us the working capital we need to bring the company to the next level of success."

Asoyia's ability to meet demand depends on the participation of farmers willing to grow a specialty identity-preserved soybean in lieu of commodity soybeans or corn. The infusion of funding will allow Asoyia's production division to develop an expanding business development team, as well as more delivery points throughout the Midwest. Asoyia will continue to work closely with various genetic suppliers of the 1% ULTRA low lin soybean genetics to develop additional new varieties with improved yield potential and various disease resistance characteristics. Additionally, Asoyia will be better able to capitalize on its strong foothold in the 1% ULTRA low lin soybean seed market by continuing to collaborate with several key seed partners to maximize distribution throughout the entire grain belt region.

"Now we'll be better able to inform farmers, and the agricultural industry in general, that we have a product that is not only unique and profitable, but also good for consumer health and the environment," Keeley explained.

"Asoyia's ULTRA low linolenic soybean products meet a critical need in the marketplace for trans-fat-free alternatives," said Dan Broderick, managing director of Prolog and new board member of Asoyia. "The company's proven products, combined with its seasoned management team, create a strong competitive edge for Asoyia."

Jorg Riesmeier, general partner at LSP and new Asoyia board member said, "LSP is very excited to be part of the Series A round in Asoyia, as the company has already built a track record of success with key soybean oil customers and soybean growers. We look forward to helping Asoyia expand its reach to meet the growing demand for its products."

For more information about Asoyia and Asoyia products, call (877)276-9421 or visit

About Asoyia

Formed in 2004 by 25 Iowa farmers, Asoyia grows and processes 1% ULTRA low linolenic soybeans to produce specialty trans fat-free oils. The research, testing and expansion of Asoyia's soybean genetics dates back to the 1960s at Iowa State University, where Dr. Walt Fehr and his team developed the specialty soybean.

About Prolog Ventures

Prolog is a venture capital firm specializing in life science investing. Since its launch in 2001, Prolog has financed more than 20 early-stage companies. The firm is managed by a team of professionals with extensive experience as both investors and entrepreneurs. Prolog focuses on traditional healthcare opportunities as well as emerging areas -- such as nutrition, wellness, plant science, and enabling platforms -- in which it has built one of the largest portfolios in the country. For more information on Prolog, visit

About LSP

LSP (Life Sciences Partners) is a leading independent venture capital firm, providing private equity financing to early- to mid-stage life-science companies. Since the late 1980s, LSP's management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With more than $500 million under management and offices in Amsterdam, Munich and Boston, LSP is one of most experienced specialist life-science investors. Further information on Life Science Partners is available at


Andrea James

Office: (515)223-1383

Cell: (515) 473-2823

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Asoyia Announces New Mid Oleic Ultra Low Lin Soybean Oil
2. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
3. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
4. UI licensee Optherion secures $37 million in financing
5. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
6. Piedmont Pharmaceuticals Secures $8.5 Million Investment
7. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
8. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
9. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
10. SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
11. InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group
Post Your Comments:
(Date:10/10/2015)... ... ... walk with crutches for the rest of my life," said an inventor from San Diego, ... give me more independence and freedom would be amazing. This inspired me to invent a ... STRAP IN to enable an individual to walk with crutches without having to use his ...
(Date:10/10/2015)... ... October 10, 2015 , ... The Bank of America 500 NASCAR ... Saturday, October 10th, defending race winner, Kevin Harvick, will battle it out ... Earnhardt Jr., and all of the stars of the NASCAR Sprint Cup Series. ...
(Date:10/10/2015)... ... 2015 , ... Attending medical school and working on a ... children. Depending on the school, the exact details of the medical program differ; ... in a medical school must complete undergraduate classwork and requirements before moving into ...
(Date:10/10/2015)... ... October 10, 2015 , ... Well-known ... pleased to be recognized by The National Law Journal for inclusion in their ... law firms across the United States who obtained the largest awards for their ...
(Date:10/9/2015)... ... October 09, 2015 , ... Doctors on Liens has ... , to provide highly needed medical care to personal injury victims. When personal ... to diagnose, document and treat the variety of conditions ailing them. With the ...
Breaking Medicine News(10 mins):
... Report: , , Study highlights: , , Cardiac ... EMS personnel due to a number of external factors. , ... to give high-quality CPR and other resuscitation efforts before transporting ... guidelines for transporting cardiac arrest patients and determining when to ...
... Pioneering procedure aims to repair damaged cardiac muscle, surgeons say ... they,ve performed the first procedure in which a patient received ... attack damage. , The 39-year-old man is the first of ... a phase 1 clinical trial being conducted at Cedars-Sinai Heart ...
... obliged to bring unresponsive patient to hospital, study finds , ... heart attack that occurs outside of a hospital are slim, ... hospital anyway because a variety of factors keep them from ... In the United States, paramedics treat almost 300,000 people with ...
... don,t perform better than standard criteria, study finds , ... cardiac risk, such as inflammation-linked C-reactive protein (CRP), ... factors such as smoking, obesity, high cholesterol and physical ... markers have been touted as a better way of ...
... Physiological changes associated with the metabolic syndrome may play ... according to study results published in Cancer Epidemiology, ... Association for Cancer Research. The metabolic syndrome, ... factors including abdominal obesity, high blood glucose levels, impaired ...
... improperly , TUESDAY, June 30 (HealthDay News) -- ... dose for Tylenol and other pain medications should be ... recommended lowering the maximum dose of over-the-counter acetaminophen -- ... , Part of the problem, according to an FDA ...
Cached Medicine News:
(Date:10/9/2015)... REDWOOD CITY, Calif. , Oct. 9, 2015 ... a presentation will be made at the annual European Society ... th to October 14 th , 2015 at the ...  The annual EuSEM is the largest meeting of emergency medicine ... and 90 countries represented. Data from the previously ...
(Date:10/9/2015)... El ,JCA-Mauvernay Award 2015, se ha otorgado ... Junko Takita    --> El ,JCA-Mauvernay ... Yutaka Kondo y Junko Takita    ... ha otorgado a los doctores Yutaka Kondo ... compañía biofarmacéutica global con sede enSuiza, presentará el ,JCA-Mauvernay Award, el 10 de ...
(Date:10/8/2015)... , Oct. 8, 2015  Ardelyx, Inc. ... focused on gastrointestinal and cardio-renal diseases, today announced ... candidate, tenapanor, will be presented at the 2015 ... findings will include measures of sustained response in ... blind, placebo-controlled, randomized Phase 2 trial. The meeting ...
Breaking Medicine Technology:
... - Diatos SA, an international,biopharmaceutical company focusing ... anti-cancer drugs, today announced,that they presented data ... their,anti-cancer compound, DTS-201, at the 43rd Annual ... (ASCO) in Chicago, USA., DTS-201 is a ...
... June 04, 2007 /PRNewswire-FirstCall/ -- BSD,Medical Corp. announced ... Phase III clinical trial testing the benefit of ... annual,American Society of Clinical Oncology (ASCO) conference underway ... clinical study,which was conducted at nine major European ...
Cached Medicine Technology:
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
... Distriman is a ... that is designed to ... used with Gilson DistriTip ... polypropylene syringes with level ...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
... Plus, a handheld manual dispenser, is ideal ... long series pipetting. Its increased volume selection ... research tasks, and its smooth handling reduces ... The nine Combitips allow a wider range ...
Medicine Products: